The UK lung cancer outcomes compare poorly in relation to its European neighbours. The incidence rates for lung cancer in the UK are higher than in Europe - 45.1 per 100,000 people in the UK and 44.1 per 100,000 on average in Europe.
The mortality rate of UK patients with lung cancer is also higher than the European average and the rate across all other EURO5. Whilst the European average mortality rate for lung cancer is 36.5 per 100,000 of the population, the UK mortality rate is 38.8 per 100,000.
Survival rates for lung cancer since 1990 have increased almost everywhere across Europe. UK survival rates have also increased; however, the chances of survival for UK patients at five years after diagnosis are 4% lower than the European average.
EUROCARE, database 5, 2014.
EUROCARE, Data and methods, 2014. Available at https://w3.iss.it/site/EU5Results/docs/Documentation_on_data_and_methods.pdf
When compared to other cancers, patient experience with lung cancer in the UK presents a mixed picture.
According to the 2015 National Cancer Patient Experience Survey, which surveys over 100,000 cancer patients in the UK, lung cancer patients rated their speed of diagnosis and understanding of their condition as better than patients with other types of cancer.
However, three out of ten people with lung cancer stated that they were not aware of the treatment options available to them, suggesting that further improvements need to be made in increasing patient awareness of the advantages and disadvantages of different treatment options.